c-IAP2 is induced by ionizing radiation through NF-kappaB binding sites

Area of Science:

• Molecular Biology
• Radiotherapy
• Gene Therapy

Background:

• Transcriptional promoters activated by low-dose X-irradiation offer potential for novel gene therapy strategies.
• Combining gene therapy with radiotherapy could enhance cancer treatment efficacy.

Purpose of the Study:

• To identify genes with X-ray-responsive promoters for gene therapy applications.
• To investigate the role of cis-elements in X-ray-induced transcriptional activation of c-IAP2.
• To develop a radiation-inducible suicide gene system for cancer therapy.

Main Methods:

• Retrovirus-mediated gene trap screening to identify X-ray-responsive genes.
• Analysis of cis-elements within the c-IAP2 promoter, focusing on NF-kappaB binding sites.
• Construction of a plasmid (p4NFB-BAX) containing NF-kappaB binding sites linked to the BAX suicide gene.
• Transfection of human tumor cells with p4NFB-BAX and assessment of cell survival post-irradiation.

Main Results:

• The c-IAP2 gene was identified as possessing an X-ray-responsive promoter.
• NF-kappaB binding sites within the c-IAP2 promoter were found to be necessary and sufficient for X-ray responsiveness.
• Transfection of human tumor cells with the p4NFB-BAX plasmid resulted in a significant reduction in cell survival following 2 Gy X-irradiation.

Conclusions:

• NF-kappaB binding sites mediate X-ray inducibility of the c-IAP2 promoter.
• The constructed p4NFB-BAX plasmid demonstrates potential as a radiation-inducible suicide gene system.
• This approach holds promise for enhancing the efficacy of radiotherapy through targeted gene therapy.